Search

everythinglearnresearchcommunity

for

Search:↓

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Certain genetic variants in keratins increase the risk of tooth decay.

Scientists made nanoparticles from human hair proteins to improve drug delivery.

PrrH sRNA controls pyochelin gene expression in Pseudomonas aeruginosa based on heme levels.

Para-aminobenzoic acid in hair supplements can cause autoimmune hepatitis.

Nanoformulated plant compounds show promise for treating PCOS but need more testing and validation.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Calcitriol and metformin together are more effective for treating PCOS and lowering MCP-1 than metformin alone.

The herbal cream was found to be a safe and effective alternative for hair growth, similar to minoxidil.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

New psoriasis treatments are effective but come with side effects and risks.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Polycaprolactone gel is effective and safe for treating nasolabial folds.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Keratosis Pilaris Atrophicans causes skin scarring and might be treated with a new synthetic retinoid.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

Nanostructured lipid carriers can effectively deliver spironolactone to hair follicles for treating hair loss.

Nilotinib can cause generalized keratosis pilaris.

Low dose valproic acid treatment caused hair loss in a young patient.

Finasteride may help reduce impulsivity caused by pramipexole.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.